Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update

NEXT STORY
Global Neurological Therapies Market Research Report 2021: Competitive Landscape and Pipeline Analysis Focusing Specifically on Therapeutic Interventions for Neurodegenerative Diseases
PREV STORY
atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PRA Health Sciences sedia meneroka keperluan Akta RACE untuk onkologi pediatrik

author_avatar
NASDAQ Market News

HTG Molecular Diagnostics Reports Second Quarter 2018 Results

Revenue increased 179% and 190%, respectively, compared to the three and six-month periods in ...

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights

author_avatar
NASDAQ Market News